US Broker Ratings

Catalyst Pharmaceuticals (CPRX): Growth Potential and Analyst Consensus Highlight Investment Opportunity

Catalyst Pharmaceuticals, Inc. (NASDAQ: CPRX) is drawing significant attention from the investing community, with its substantial potential upside and robust analyst consensus setting it apart in the biotechnology sector. Based..

Certara, Inc. (CERT)

⚠️ No article content returned.

..

BioCryst Pharmaceuticals, Inc. (BCRX): Investor Outlook on a Potential 91% Upside

BioCryst Pharmaceuticals, Inc. (NASDAQ: BCRX) offers a compelling case for investors seeking opportunities in the healthcare sector, particularly within the niche of rare disease therapeutics. With a market capitalization of..

HUTCHMED (China) Limited (HCM) Stock Analysis: A 40.5% Potential Upside in the Healthcare Sector

HUTCHMED (China) Limited (NASDAQ: HCM), a prominent player in the healthcare sector, stands at an intriguing juncture for investors, offering a substantial potential upside of 40.5% according to analyst ratings...

PTC Therapeutics, Inc. (PTCT) Stock Analysis: A Promising 28.95% Potential Upside in the Biotech Sector

PTC Therapeutics, Inc. (NASDAQ: PTCT), a biopharmaceutical leader in the biotechnology sector, is making waves with its focus on developing treatments for rare disorders. Headquartered in Warren, New Jersey, PTC..

Protagonist Therapeutics, Inc. (PTGX) Stock Analysis: Exploring a 28.18% Potential Upside in Biotechnology

Protagonist Therapeutics, Inc. (NASDAQ: PTGX), headquartered in Newark, California, is a dynamic player in the biotechnology sector, with a current market capitalization of $3.34 billion. The company is dedicated to..

Amedisys Inc (AMED) Stock Analysis: Navigating the Healthcare Sector with a Forward P/E of 19.43

Amedisys Inc (AMED), a prominent player in the healthcare sector, operates within the medical care facilities industry in the United States. With a market capitalization of $3.24 billion, Amedisys specializes..

Alignment Healthcare, Inc. (ALHC) Stock Analysis: A Look at Its 38% Potential Upside

For investors seeking opportunities in the healthcare sector, Alignment Healthcare, Inc. (NASDAQ: ALHC) presents an intriguing proposition. With a market capitalization of $2.71 billion, this Orange, California-based company is making..

Amneal Pharmaceuticals, Inc. (AMRX) Stock Analysis: Exploring a 47.61% Upside Potential

Amneal Pharmaceuticals, Inc. (AMRX) has recently caught the attention of investors with its compelling growth prospects and a substantial upside potential of 47.61%. Trading at $7.96, the company’s stock is..

MoonLake Immunotherapeutics (MLTX) Stock Analysis: A 45% Upside Potential in the Biotech Arena

MoonLake Immunotherapeutics (NASDAQ: MLTX), a clinical-stage biotechnology company headquartered in Zug, Switzerland, is capturing investor attention with its innovative approach to treating inflammatory skin and joint diseases. Despite its relatively..

Sotera Health Company (SHC) Stock Analysis: A 29% Upside Potential Awaits Healthcare Investors

Sotera Health Company (NASDAQ: SHC), a pivotal player in the healthcare sector specializing in diagnostics and research, presents an intriguing opportunity for investors seeking exposure to the medical and pharmaceutical..

Alvotech (ALVO) Stock Analysis: Unpacking the 97% Upside Potential in the Biosimilar Market

Alvotech (NASDAQ: ALVO), a Luxembourg-based powerhouse in the healthcare sector specializing in biosimilar medicines, is catching the eye of investors with its impressive growth trajectory and significant upside potential. With..

Arcellx, Inc. (ACLX) Stock Analysis: Exploring a Potential 57.88% Upside in Biotech Innovation

Arcellx, Inc. (ACLX) is making waves in the healthcare sector, particularly within the biotechnology industry, as it continues to develop groundbreaking immunotherapies aimed at tackling cancer and other incurable diseases...

DENTSPLY SIRONA Inc. (XRAY) Stock Analysis: Exploring a 27% Upside Potential with a Solid Dividend Yield

DENTSPLY SIRONA Inc. (NASDAQ: XRAY), a prominent player in the healthcare sector, has caught the attention of investors with its diverse product offerings and potential upside. As the company navigates..

ACADIA Pharmaceuticals Inc. (ACAD) Stock Analysis: Robust Growth and Promising Upside Potential

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) is capturing investor attention with its strategic focus on developing and commercializing treatments for central nervous system (CNS) disorders and rare diseases. With a market..

Haemonetics Corporation (HAE) Stock Analysis: Evaluating a 21.17% Potential Upside in the Healthcare Sector

Haemonetics Corporation (NYSE: HAE), a key player in the medical devices industry, offers a compelling investment opportunity within the healthcare sector. With a market capitalization of $3.67 billion, Haemonetics stands..

SpringWorks Therapeutics, Inc. (SWTX) Stock Analysis: Navigating Biotech’s Growth Frontier

SpringWorks Therapeutics, Inc. (NASDAQ: SWTX) has established itself as a noteworthy player in the biotechnology sector, with a specific focus on developing therapies for rare diseases and certain types of..

Lantheus Holdings, Inc. (LNTH) Investor Outlook: Exploring a 76% Potential Upside with Strong Buy Ratings

Investors looking for promising opportunities in the healthcare sector might want to pay close attention to Lantheus Holdings, Inc. (NASDAQ: LNTH). With a robust portfolio of diagnostic and therapeutic products..

Krystal Biotech, Inc. (KRYS) Stock Analysis: A 32% Potential Upside in Biotech Innovation

Krystal Biotech, Inc. (NASDAQ: KRYS), a burgeoning player in the biotechnology sector, is capturing the attention of investors with its promising portfolio of genetic medicines. Headquartered in Pittsburgh, Pennsylvania, this..

iRhythm Technologies, Inc. (IRTC) Stock Analysis: A Healthcare Game Changer with a 5.93% Upside Potential

iRhythm Technologies, Inc. (NASDAQ: IRTC) is making waves in the healthcare sector with its innovative approach to cardiac monitoring. As a leader in the medical devices industry, iRhythm is reshaping..

US Broker Ratings

US Broker Ratings

FTSE 100

Funds